SAS Output

22-SEP-2017 18:10

GU ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S1314-Blad, COXEN Neoadj. Chemo + Cyst 1 Y 1 GC+CYST 230 113 48 27 12 5 1 08/28/2014 223 118
        2 DDMVAC+CYST   111 47 28 14 6 2      
            224 95 55 26 11 3      
 
  S1500-pRCC,Adv, Sunitinib vs MET inhib 1 Y 1 Sunitinib 180 13 12 4 3 1 0 07/25/2016 196 87
        2 Cabozantinib   12 10 4 3 2 0      
        3 Crizotinib   13 11 5 3 2 1      
        4 Savolitinib   12 10 5 1 0 0      
            50 43 18 10 5 1      
 
  S1602-Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 Y 1 TICE BCG 969 10 10 9 5 2 0 02/24/2017 136 61
        2 Tokyo-172 BCG   11 11 11 8 4 2      
        3 Prime + Tokyo-172 BCG   11 11 10 8 2 2      
            32 32 30 21 8 4      
 
  S1605-Blad, BCG-Unresponsive NMIBC, Atezolizumab 1 Y 1 Atezolizumab 148 11 11 10 6 4 1 03/13/2017 133 58
            11 11 10 6 4 1      
 
Yes A031102-GCT, Recur, Std Chemo(TIP) vs HD Chemo(TI-CE) 1 E Total Registrations   2 2 0 0 0 0 11/23/2016 56 33
            2 2 0 0 0 0      
 
  NRGGU002-Pros, RT + ADT After RP +/- Adj Docetaxel 1 E Total Registrations   1 1 1 1 1 0 08/24/2017   6
            1 1 1 1 1 0      
 
    2 E Total Registrations   1 1 1 1 1 1 08/24/2017    
            1 1 1 1 1 1      
 
No EA8141-UTUC, HG, Chemo then Surg 1 E Total Registrations   8 4 2 0 0 0 02/23/2016 153 75
            8 4 2 0 0 0      
 
  R0924-Pros, NADT+WPRT vs. NADT+P&SV RT 1 E Total Registrations   52 25 12 6 1 1 11/25/2013   163
            52 25 12 6 1 1